AVITA Medical (RCEL)
AVITA Medical on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as surgical & medical instruments & apparatus.
2.8M
Short interest
settlement 2026-10-15
7.6
Days to cover
-1.6 days vs prior
45.2%
Short share of volume
2026-11-02
576
Fails to deliver
settlement 2026-10-09
Thu 5 Nov
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in RCEL is 2,835,905 shares, down 49,788 shares over the last month. Over the last 48 readings it ranged from 1,024,101 shares (15 November 2024) to 5,824,470 shares (31 July 2025). At the reported average volume of 372K shares a day that is 7.6 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/rcel" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 2,835,905 | -1.8% | 371,656 | 7.63 |
| 2026-09-30 | 2,887,981 | +0.1% | 313,878 | 9.20 |
| 2026-09-15 | 2,885,693 | -1.8% | 273,719 | 10.54 |
| 2026-08-31 | 2,938,029 | +6.9% | 424,104 | 6.93 |
| 2026-08-14 | 2,748,578 | +5.4% | 1,099,441 | 2.50 |
| 2026-07-31 | 2,607,471 | -0.4% | 234,966 | 11.10 |
| 2026-07-15 | 2,617,186 | +3.5% | 337,778 | 7.75 |
| 2026-06-30 | 2,529,951 | -21.5% | 421,835 | 6.00 |
| 2026-06-15 | 3,223,498 | -2.3% | 239,370 | 13.47 |
| 2026-05-29 | 3,299,835 | -7.0% | 215,061 | 15.34 |
| 2026-05-15 | 3,548,579 | +3.8% | 318,201 | 11.15 |
| 2026-04-30 | 3,417,316 | -4.0% | 165,487 | 20.65 |
| 2026-04-15 | 3,561,646 | -6.8% | 269,123 | 13.23 |
| 2026-03-31 | 3,823,735 | +3.3% | 218,247 | 17.52 |
| 2026-03-13 | 3,703,375 | -2.9% | 179,009 | 20.69 |
| 2026-02-27 | 3,815,107 | +1.7% | 240,500 | 15.86 |
| 2026-02-13 | 3,750,615 | -0.4% | 231,337 | 16.21 |
| 2026-01-30 | 3,765,438 | +5.8% | 204,048 | 18.45 |
| 2026-01-15 | 3,557,351 | +14.5% | 243,795 | 14.59 |
| 2025-12-31 | 3,106,959 | +2.4% | 213,760 | 14.53 |
| 2025-12-15 | 3,034,086 | +0.7% | 183,603 | 16.53 |
| 2025-11-28 | 3,014,399 | -0.1% | 215,885 | 13.96 |
| 2025-11-14 | 3,017,151 | +3.8% | 173,790 | 17.36 |
| 2025-10-31 | 2,906,014 | -8.2% | 339,004 | 8.57 |
| 2025-10-15 | 3,164,050 | -4.4% | 131,662 | 24.03 |
| 2025-09-30 | 3,310,626 | -26.9% | 478,249 | 6.92 |
| 2025-09-15 | 4,531,094 | -1.4% | 2,151,280 | 2.11 |
| 2025-08-29 | 4,596,834 | -14.5% | 309,166 | 14.87 |
| 2025-08-15 | 5,378,544 | -7.7% | 552,865 | 9.73 |
| 2025-07-31 | 5,824,470 | +2.1% | 260,011 | 22.40 |
| 2025-07-15 | 5,705,617 | +4.1% | 275,590 | 20.70 |
| 2025-06-30 | 5,480,770 | +22.2% | 322,972 | 16.97 |
| 2025-06-13 | 4,486,349 | +13.3% | 337,178 | 13.31 |
| 2025-05-30 | 3,960,286 | +7.7% | 259,211 | 15.28 |
| 2025-05-15 | 3,677,068 | +23.6% | 404,228 | 9.10 |
| 2025-04-30 | 2,974,627 | +6.5% | 124,378 | 23.92 |
| 2025-04-15 | 2,793,419 | +13.9% | 246,613 | 11.33 |
| 2025-03-31 | 2,451,757 | +4.4% | 156,034 | 15.71 |
| 2025-03-14 | 2,349,331 | +36.0% | 254,324 | 9.24 |
| 2025-02-28 | 1,726,956 | -10.9% | 193,382 | 8.93 |
| 2025-02-14 | 1,939,295 | +7.2% | 210,935 | 9.19 |
| 2025-01-31 | 1,808,555 | -0.2% | 151,957 | 11.90 |
| 2025-01-15 | 1,812,781 | +24.5% | 358,419 | 5.06 |
| 2024-12-31 | 1,455,535 | +25.9% | 144,376 | 10.08 |
| 2024-12-13 | 1,156,538 | -1.3% | 93,232 | 12.40 |
| 2024-11-29 | 1,171,126 | +14.4% | 103,583 | 11.31 |
| 2024-11-15 | 1,024,101 | -14.3% | 135,919 | 7.53 |
| 2024-10-31 | 1,194,836 | -10.6% | 52,100 | 22.93 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of RCEL volume is 45.2%, down 32.0 points over the last five sessions. Over the last 30 readings it ranged from 45.2% (2 November 2026) to 82.0% (29 September 2026). The latest reading sits at the bottom of that range. The latest reading is 18.7 points below the 30-session average of 63.9%, on 249K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 112K | 249K | 45.2% | 0 |
| 2026-10-30 | 140K | 270K | 51.7% | 6 |
| 2026-10-29 | 53K | 116K | 45.4% | 0 |
| 2026-10-28 | 121K | 215K | 56.3% | 1,500 |
| 2026-10-27 | 159K | 214K | 74.1% | 0 |
| 2026-10-26 | 111K | 143K | 77.2% | 0 |
| 2026-10-23 | 120K | 202K | 59.2% | 692 |
| 2026-10-22 | 189K | 292K | 64.9% | 0 |
| 2026-10-21 | 248K | 373K | 66.4% | 40 |
| 2026-10-20 | 111K | 169K | 66.1% | 2,150 |
| 2026-10-19 | 85K | 115K | 73.8% | 1 |
| 2026-10-16 | 85K | 154K | 55.1% | 1,031 |
| 2026-10-15 | 92K | 159K | 58.0% | 3,134 |
| 2026-10-14 | 124K | 229K | 54.0% | 3,002 |
| 2026-10-13 | 83K | 130K | 63.9% | 0 |
| 2026-10-12 | 91K | 158K | 57.4% | 6,316 |
| 2026-10-09 | 81K | 135K | 59.7% | 127 |
| 2026-10-08 | 90K | 127K | 70.7% | 0 |
| 2026-10-07 | 84K | 120K | 70.1% | 0 |
| 2026-10-06 | 154K | 220K | 69.7% | 0 |
| 2026-10-05 | 154K | 224K | 69.0% | 4,088 |
| 2026-10-02 | 117K | 176K | 66.5% | 0 |
| 2026-10-01 | 115K | 168K | 68.5% | 4,300 |
| 2026-09-30 | 86K | 128K | 66.9% | 0 |
| 2026-09-29 | 103K | 125K | 82.0% | 0 |
| 2026-09-28 | 58K | 91K | 63.1% | 180 |
| 2026-09-25 | 114K | 172K | 66.5% | 4,183 |
| 2026-09-24 | 144K | 183K | 78.4% | 100 |
| 2026-09-23 | 70K | 121K | 57.8% | 0 |
| 2026-09-22 | 158K | 265K | 59.9% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 9 October 2026, the fails-to-deliver balance in RCEL is 576 shares, up 76 shares over the last settlement date. Over the last 30 readings it ranged from 2 shares (17 August 2026) to 173,756 shares (10 August 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-09 | 576 | $13.33 | $8K |
| 2026-10-05 | 500 | $12.72 | $6K |
| 2026-09-29 | 2,654 | $11.67 | $31K |
| 2026-09-28 | 425 | $11.84 | $5K |
| 2026-09-25 | 5,000 | $11.58 | $58K |
| 2026-09-24 | 375 | $10.95 | $4K |
| 2026-09-23 | 375 | $11.49 | $4K |
| 2026-09-21 | 5,062 | $11.02 | $56K |
| 2026-09-08 | 4,000 | $11.20 | $45K |
| 2026-09-03 | 1,139 | $10.76 | $12K |
| 2026-09-02 | 3 | $10.07 | $30 |
| 2026-08-27 | 3,832 | $10.59 | $41K |
| 2026-08-24 | 10 | $10.06 | $101 |
| 2026-08-21 | 1,158 | $10.09 | $12K |
| 2026-08-20 | 23,689 | $10.34 | $245K |
| 2026-08-19 | 70,780 | $9.85 | $697K |
| 2026-08-18 | 9,632 | $7.90 | $76K |
| 2026-08-17 | 2 | $7.85 | $16 |
| 2026-08-14 | 6,530 | $8.01 | $52K |
| 2026-08-12 | 4,467 | $8.20 | $37K |
| 2026-08-11 | 12,848 | $7.60 | $98K |
| 2026-08-10 | 173,756 | $7.77 | $1.4M |
| 2026-08-07 | 42,663 | $4.75 | $203K |
| 2026-07-30 | 916 | $4.44 | $4K |
| 2026-07-29 | 955 | $4.61 | $4K |
| 2026-07-27 | 4,243 | $4.61 | $20K |
| 2026-07-22 | 5,000 | $5.09 | $25K |
| 2026-07-21 | 14,282 | $5.14 | $73K |
| 2026-07-20 | 7,657 | $5.10 | $39K |
| 2026-07-17 | 10,000 | $4.98 | $50K |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for RCEL in the last 90 days. The most recent filings are listed below. Latest filing: O'Toole David D (CFO) on 2026-06-12.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-06-12 | O'Toole David D | CFO | Grant | 2K | $3.97 | $8K | 153K |
| 2026-06-09 | Woody Joseph Fralin | Director | Buy | 5K | $4.18 | $21K | 103K |
| 2026-06-09 | Woody Joseph Fralin | Director | Buy | 5K | $4.20 | $21K | 98K |
| 2026-06-09 | Woody Joseph Fralin | Director | Buy | 5K | $4.00 | $21K | 108K |
| 2026-06-03 | Woody Joseph Fralin | Director | Buy | 5K | $4.09 | $20K | 93K |
| 2026-06-03 | Woody Joseph Fralin | Director | Buy | 5K | $4.10 | $20K | 88K |
| 2026-06-02 | Woody Joseph Fralin | Director | Buy | 5K | $4.21 | $21K | 20K |
| 2026-06-02 | Woody Joseph Fralin | Director | Buy | 5K | $4.18 | $21K | 15K |
| 2026-06-01 | Woody Joseph Fralin | Director | Buy | 5K | $4.26 | $21K | 10K |
| 2026-06-01 | Woody Joseph Fralin | Director | Buy | 5K | $4.34 | $22K | 5K |
| 2026-05-29 | O'Toole David D | CFO | Grant | 5K | $3.05 | $15K | 151K |
| 2026-05-29 | Vance Cary Guy | President and CEO | Grant | 5K | $3.05 | $15K | 41K |
| 2026-05-20 | O'Toole David D | CFO | Buy | 2K | $4.26 | $9K | 146K |
| 2026-05-19 | O'Toole David D | CFO | Buy | 2K | $4.24 | $8K | 144K |
| 2026-03-11 | O'Toole David D | CFO | Buy | 2K | $4.78 | $9K | 142K |
| 2026-02-19 | O'Toole David D | CFO | Buy | 3K | $4.15 | $12K | 140K |
| 2026-02-18 | KELSEY NICOLE | Chief Legal Officer | Grant | 98K | price not stated in the filing | not stated | 98K |
| 2026-02-18 | O'Toole David D | CFO | Grant | 105K | price not stated in the filing | not stated | 137K |
| 2026-01-20 | REED JAN STERN | Director | Grant | 22K | price not stated in the filing | not stated | 73K |
| 2026-01-20 | Crowe Suzanne | Director | Grant | 22K | price not stated in the filing | not stated | 69K |
| 2026-01-20 | COOK JEREMY CURNOCK | Director | Grant | 22K | price not stated in the filing | not stated | 62K |
| 2026-01-20 | Tarnoff Michael E | Director | Grant | 22K | price not stated in the filing | not stated | 48K |
| 2026-01-20 | Woody Joseph Fralin | Director | Grant | 22K | price not stated in the filing | not stated | 83K |
| 2026-01-20 | McNamara Robert | Director | Grant | 22K | price not stated in the filing | not stated | 109K |
| 2026-01-05 | Woody Joseph Fralin | Director | Grant | 41K | price not stated in the filing | not stated | 61K |
| 2025-08-28 | McNamara Robert | Director | Buy | 10K | $4.50 | $45K | 87K |
| 2025-08-26 | O'Toole David D | CFO | Buy | 2K | $4.52 | $9K | 32K |
| 2025-08-19 | McNamara Robert | Director | Buy | 10K | $5.00 | $50K | 77K |
| 2025-08-12 | O'Toole David D | CFO | Buy | 2K | $4.81 | $10K | 30K |
| 2025-08-06 | Tarnoff Michael E | Director | Grant | 26K | price not stated in the filing | not stated | 26K |
| 2025-05-30 | O'Toole David D | CFO | Grant | 2K | $4.78 | $9K | 28K |
| 2025-03-06 | McNamara Robert | Director | Buy | 11K | $8.30 | $91K | 57K |
| 2025-02-20 | O'Toole David D | CFO | Buy | 1K | $9.90 | $10K | 26K |
| 2025-02-20 | McNamara Robert | Director | Buy | 10K | $10.09 | $101K | 46K |
| 2025-02-19 | O'Toole David D | CFO | Buy | 1K | $10.25 | $10K | 25K |
| 2025-01-21 | Panaccio Lou | Director | Grant | 10K | price not stated in the filing | not stated | 56K |
| 2025-01-21 | Crowe Suzanne | Director | Grant | 10K | price not stated in the filing | not stated | 47K |
| 2025-01-21 | COOK JEREMY CURNOCK | Director | Grant | 10K | price not stated in the filing | not stated | 40K |
| 2025-01-21 | McNamara Robert | Director | Grant | 10K | price not stated in the filing | not stated | 67K |
| 2025-01-21 | REED JAN STERN | Director | Grant | 10K | price not stated in the filing | not stated | 51K |
| 2025-01-21 | Vance Cary Guy | Director | Grant | 10K | price not stated in the filing | not stated | 36K |
| 2024-12-09 | Crowe Suzanne | Director | Buy | 486 | $13.15 | $6K | 37K |
| 2024-12-05 | O'Toole David D | CFO | Buy | 500 | $12.40 | $6K | 24K |
| 2024-12-05 | O'Toole David D | CFO | Buy | 475 | $12.53 | $6K | 23K |
| 2024-11-29 | O'Toole David D | CFO | Grant | 785 | $7.83 | $6K | 23K |
| 2024-08-19 | McNamara Robert | Director | Grant | 10K | $9.00 | $90K | 36K |
| 2024-06-05 | Vance Cary Guy | Director | Grant | 9K | price not stated in the filing | not stated | 26K |
| 2024-06-05 | McNamara Robert | Director | Grant | 9K | price not stated in the filing | not stated | 26K |
| 2024-06-05 | REED JAN STERN | Director | Grant | 9K | price not stated in the filing | not stated | 41K |
| 2024-06-05 | COOK JEREMY CURNOCK | Director | Grant | 9K | price not stated in the filing | not stated | 30K |
| 2024-06-05 | Crowe Suzanne | Director | Grant | 9K | price not stated in the filing | not stated | 36K |
| 2024-06-05 | Panaccio Lou | Director | Grant | 9K | price not stated in the filing | not stated | 46K |
| 2024-05-31 | O'Toole David D | CFO | Grant | 2K | $8.17 | $18K | 22K |
| 2024-05-31 | Shiroma Donna | General Counsel | Grant | 2K | $8.17 | $18K | 46K |
| 2024-05-30 | O'Toole David D | CFO | Buy | 500 | $8.60 | $4K | 20K |
| 2024-05-30 | O'Toole David D | CFO | Buy | 500 | $9.20 | $5K | 19K |
| 2024-02-28 | O'Toole David D | CFO | Buy | 250 | $17.43 | $4K | 19K |
| 2024-02-28 | O'Toole David D | CFO | Buy | 1K | $17.38 | $17K | 18K |
| 2023-12-26 | CORBETT JAMES | CEO | Sell | 1K | $13.29 | $19K | 12K |
| 2023-12-21 | COOK JEREMY CURNOCK | Director | Sell | 3K | $12.49 | $31K | 21K |
| 2023-12-13 | COOK JEREMY CURNOCK | Director | Sell | 3K | $12.27 | $31K | 21K |
| 2023-12-12 | O'Toole David D | CFO | Buy | 950 | $12.45 | $12K | 17K |
| 2023-12-01 | O'Toole David D | CFO | Buy | 500 | $10.68 | $5K | 17K |
| 2023-11-30 | Shiroma Donna | General Counsel | Grant | 1K | $9.06 | $13K | 44K |
| 2023-11-30 | O'Toole David D | CFO | Grant | 1K | $9.06 | $9K | 16K |
| 2023-11-21 | O'Toole David D | CFO | Buy | 1K | $10.30 | $10K | 14K |
| 2023-11-21 | O'Toole David D | CFO | Buy | 1K | $10.26 | $10K | 15K |
| 2023-11-16 | O'Toole David D | CFO | Buy | 1K | $12.15 | $12K | 12K |
| 2023-11-15 | O'Toole David D | CFO | Buy | 1K | $13.25 | $13K | 11K |
| 2023-11-15 | O'Toole David D | CFO | Buy | 1K | $12.45 | $12K | 13K |
| 2023-11-14 | O'Toole David D | CFO | Buy | 1K | $12.88 | $13K | 10K |
| 2023-08-21 | Shiroma Donna | General Counsel | Sell | 4K | $15.84 | $66K | 42K |
| 2023-08-16 | O'Toole David D | CFO | Buy | 1K | $17.05 | $17K | 8K |
| 2023-08-16 | O'Toole David D | CFO | Buy | 1K | $17.06 | $17K | 9K |
| 2023-08-15 | O'Toole David D | CFO | Buy | 1K | $17.93 | $18K | 7K |
| 2023-08-15 | O'Toole David D | CFO | Buy | 1K | $17.96 | $18K | 5K |
| 2023-08-15 | O'Toole David D | CFO | Buy | 1K | $17.89 | $18K | 4K |
| 2023-08-15 | O'Toole David D | CFO | Buy | 1K | $17.92 | $18K | 3K |
| 2023-08-15 | O'Toole David D | CFO | Buy | 1K | $17.94 | $18K | 6K |
| 2023-06-20 | O'Toole David D | CFO | Buy | 1K | $16.15 | $16K | 2K |
| 2023-06-06 | COOK JEREMY CURNOCK | Director | Grant | 6K | price not stated in the filing | not stated | 23K |
| 2023-06-06 | Crowe Suzanne | Director | Grant | 6K | price not stated in the filing | not stated | 27K |
| 2023-06-06 | McNamara Robert | Director | Grant | 6K | price not stated in the filing | not stated | 17K |
| 2023-06-06 | McNamara Robert | Director | Grant | 10K | price not stated in the filing | not stated | 10K |
| 2023-06-06 | Panaccio Lou | Director | Grant | 6K | price not stated in the filing | not stated | 37K |
| 2023-06-06 | REED JAN STERN | Director | Grant | 6K | price not stated in the filing | not stated | 32K |
| 2023-06-06 | Vance Cary Guy | Director | Grant | 6K | price not stated in the filing | not stated | 17K |
| 2023-06-06 | Vance Cary Guy | Director | Grant | 10K | price not stated in the filing | not stated | 10K |
| 2022-12-12 | COOK JEREMY CURNOCK | Director | Grant | 13K | price not stated in the filing | not stated | 17K |
| 2022-12-12 | Crowe Suzanne | Director | Grant | 13K | price not stated in the filing | not stated | 21K |
| 2022-12-12 | Panaccio Lou | Director | Grant | 13K | price not stated in the filing | not stated | 31K |
| 2022-12-12 | REED JAN STERN | Director | Grant | 13K | price not stated in the filing | not stated | 26K |
| 2022-11-21 | PERRY MICHAEL S | Director | Exercise or conversion | 150K | $5.99 | $899K | 380K |
| 2022-11-21 | PERRY MICHAEL S | Director | Sell | 150K | $7.18 | $1.1M | 230K |
| 2022-09-01 | PERRY MICHAEL S | Chief Executive Officer | Grant | 3K | $0.00 | $0 | 301K |
| 2022-07-01 | Shiroma Donna | General Counsel | Grant | 36K | price not stated in the filing | not stated | 46K |
| 2022-07-01 | Quick Andrew | Chief Technology Officer | Grant | 36K | price not stated in the filing | not stated | 46K |
| 2022-07-01 | McGee Kathy M. | Chief Operating Officer | Grant | 36K | price not stated in the filing | not stated | 46K |
| 2022-07-01 | Liberto Erin | Chief Commercial Officer | Grant | 36K | price not stated in the filing | not stated | 46K |
| 2022-07-01 | Holder Michael | Chief Financial Officer | Grant | 36K | price not stated in the filing | not stated | 46K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSONNo holder on file reports 5% or more of RCEL in its latest filing.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-01-30 | 13G/Ano. 1 | The Vanguard Groupinvestment adviser | 1.4M | 4.7% | 2025-12-31 |
| 2025-10-17 | 13G/Ano. 1 | BlackRock, Inc.parent holding company | 1.1M | 4.3% | 2025-09-30 |
13F holders
Tracked managers holding RCEL at their latest 13F. JSON3 of the 30 tracked managers held RCEL at their latest 13F, $1.5M in total at quarter-end prices. AQR Capital Management is the largest at $1.3M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 1 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| AQR Capital Management | 2026-06-30 | 321K | $1.3M | 0.00% | +227K |
| Citadel Advisors | 2026-06-30 | 21K | $88K | 0.00% | -4K |
| Millennium Management | 2026-06-30 | 15K | $64K | 0.00% | new |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
AVITA Medical in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows AVITA Medical (RCEL), SEC CIK 1762303, listed on Nasdaq, classified by the SEC as surgical & medical instruments & apparatus. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-09.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-01-30.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-06.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-06-12.JSON and CSV
- Company record
- EDGAR filing index for CIK 1762303Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as surgical & medical instruments & apparatus
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
Datasets
Frequently Asked Questions
How much of RCEL is sold short?
2,835,905 shares were held short at the 2026-10-15 settlement, 7.6 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is RCEL's daily short volume?
On 2026-11-02, 112,481 of the 248,963 RCEL shares reported to FINRA were sold short, 45.2% of the day's reported volume. Short volume is a flow for one day, not a position.
Does RCEL have fails to deliver?
The SEC's latest file shows 576 RCEL shares failed to deliver at settlement 2026-10-09. Fails are reported per settlement date and published twice a month with a lag.
Are RCEL insiders buying or selling?
No open-market insider trades were reported for RCEL in the last 90 days. The most recent filings are listed below. Latest filing: O'Toole David D (CFO) on 2026-06-12.
Who owns 5% or more of RCEL?
No holder on file reports 5% or more of RCEL in its latest filing.
Which tracked 13F managers own RCEL?
3 of the 30 tracked 13F managers held RCEL shares at their latest filing, $1.5M in all. The largest: Cliff Asness's AQR Capital Management (321K shares, $1.3M), Ken Griffin's Citadel Advisors (21K shares, $88K), Izzy Englander's Millennium Management (15K shares, $64K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.